Atrophic Telogen Effluvium from Cytotoxic Drugs and a Randomized Controlled Trial to Investigate the Possible Protective Effect of Pretreatment with a Topical Vitamin D3 Analogue in Humans

    July 2005 in “ British Journal of Dermatology ”
    T.O. Bleiker, Nicolas Nicolaou, J. Traulsen, P.E. Hutchinson
    Studysummary This study found no protective effect of topical calcipotriol on hair loss in chemotherapy patients, and the authors propose the term "atrophic telogen effluvium" for this type of hair loss.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on academic.oup.com →
    Discuss this study in the Community →

    Research cited in this study 2

    1. Reduction of Intrafollicular Apoptosis in Chemotherapy-Induced Alopecia by Topical Calcitriol Analogs ˜The œjournal of investigative dermatology/Journal of investigative dermatology · 1998
    2. Novel Cycle Changes in Scalp Hair Are Caused by Etretinate Therapy British Journal of Dermatology · 1995

    Related research 6

    1. What Can Complex Dietary Supplements Do for Hair Loss and How Can It Be Validly Measured: A Review Applied Sciences · 2020
    2. Treatments of Hereditary Hair Loss (Alopecia) 2018
    3. Interventions for Alopecia Areata Journal of Evidence-Based Medicine · 2009
    4. Atrophic Telogen Effluvium from Cytotoxic Drugs and a Randomized Controlled Trial to Investigate the Possible Protective Effect of Pretreatment with a Topical Vitamin D3 Analogue in Humans British Journal of Dermatology · 2005
    5. Alopecia Journal of the Korean Medical Association · 2002
    6. Treatment of Hair Loss The New England Journal of Medicine · 1999